nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—Vestibular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0365	0.0367	CcSEcCtD
Moxifloxacin—Tendon disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0281	0.0282	CcSEcCtD
Moxifloxacin—Salivary gland enlargement—Cyclosporine—focal segmental glomerulosclerosis	0.0264	0.0265	CcSEcCtD
Moxifloxacin—Polyneuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0225	0.0226	CcSEcCtD
Moxifloxacin—Sensation of foreign body—Cyclosporine—focal segmental glomerulosclerosis	0.0225	0.0226	CcSEcCtD
Moxifloxacin—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.0156	0.0157	CcSEcCtD
Moxifloxacin—Nephropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0154	0.0155	CcSEcCtD
Moxifloxacin—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.0136	0.0136	CcSEcCtD
Moxifloxacin—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.0132	0.0133	CcSEcCtD
Moxifloxacin—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0125	CcSEcCtD
Moxifloxacin—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.0121	CcSEcCtD
Moxifloxacin—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.0117	0.0117	CcSEcCtD
Moxifloxacin—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.0112	0.0112	CcSEcCtD
Moxifloxacin—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0108	CcSEcCtD
Moxifloxacin—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0102	CcSEcCtD
Moxifloxacin—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0101	CcSEcCtD
Moxifloxacin—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00948	0.00954	CcSEcCtD
Moxifloxacin—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00941	0.00946	CcSEcCtD
Moxifloxacin—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00941	0.00946	CcSEcCtD
Moxifloxacin—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00933	0.00939	CcSEcCtD
Moxifloxacin—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00933	0.00939	CcSEcCtD
Moxifloxacin—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.00904	0.00909	CcSEcCtD
Moxifloxacin—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.0087	0.00876	CcSEcCtD
Moxifloxacin—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00833	0.00839	CcSEcCtD
Moxifloxacin—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00805	0.0081	CcSEcCtD
Moxifloxacin—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00805	0.0081	CcSEcCtD
Moxifloxacin—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00805	0.0081	CcSEcCtD
Moxifloxacin—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00795	0.00799	CcSEcCtD
Moxifloxacin—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00795	0.00799	CcSEcCtD
Moxifloxacin—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00795	0.00799	CcSEcCtD
Moxifloxacin—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00789	0.00794	CcSEcCtD
Moxifloxacin—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00784	0.00789	CcSEcCtD
Moxifloxacin—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00769	0.00774	CcSEcCtD
Moxifloxacin—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00746	0.0075	CcSEcCtD
Moxifloxacin—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00732	0.00737	CcSEcCtD
Moxifloxacin—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00732	0.00737	CcSEcCtD
Moxifloxacin—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.0072	0.00724	CcSEcCtD
Moxifloxacin—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00699	0.00703	CcSEcCtD
Moxifloxacin—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00691	0.00696	CcSEcCtD
Moxifloxacin—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00688	0.00692	CcSEcCtD
Moxifloxacin—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00673	0.00677	CcSEcCtD
Moxifloxacin—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00669	0.00673	CcSEcCtD
Moxifloxacin—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00669	0.00673	CcSEcCtD
Moxifloxacin—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00662	0.00666	CcSEcCtD
Moxifloxacin—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00662	0.00666	CcSEcCtD
Moxifloxacin—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00639	0.00643	CcSEcCtD
Moxifloxacin—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00636	0.00639	CcSEcCtD
Moxifloxacin—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00636	0.00639	CcSEcCtD
Moxifloxacin—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00611	0.00615	CcSEcCtD
Moxifloxacin—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00608	0.00612	CcSEcCtD
Moxifloxacin—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00605	0.00609	CcSEcCtD
Moxifloxacin—Gatifloxacin—ALB—focal segmental glomerulosclerosis	0.00601	1	CrCbGaD
Moxifloxacin—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.006	0.00603	CcSEcCtD
Moxifloxacin—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00594	0.00598	CcSEcCtD
Moxifloxacin—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00594	0.00598	CcSEcCtD
Moxifloxacin—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00592	0.00595	CcSEcCtD
Moxifloxacin—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00592	0.00595	CcSEcCtD
Moxifloxacin—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00589	0.00592	CcSEcCtD
Moxifloxacin—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00578	0.00582	CcSEcCtD
Moxifloxacin—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00566	0.00569	CcSEcCtD
Moxifloxacin—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00561	0.00564	CcSEcCtD
Moxifloxacin—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00559	0.00562	CcSEcCtD
Moxifloxacin—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00556	0.0056	CcSEcCtD
Moxifloxacin—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00552	0.00555	CcSEcCtD
Moxifloxacin—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00549	0.00553	CcSEcCtD
Moxifloxacin—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00547	0.0055	CcSEcCtD
Moxifloxacin—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00545	0.00548	CcSEcCtD
Moxifloxacin—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00545	0.00548	CcSEcCtD
Moxifloxacin—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00542	0.00546	CcSEcCtD
Moxifloxacin—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00532	0.00535	CcSEcCtD
Moxifloxacin—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00523	0.00526	CcSEcCtD
Moxifloxacin—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00523	0.00526	CcSEcCtD
Moxifloxacin—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00504	0.00507	CcSEcCtD
Moxifloxacin—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00498	0.00501	CcSEcCtD
Moxifloxacin—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00487	0.0049	CcSEcCtD
Moxifloxacin—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00486	0.00488	CcSEcCtD
Moxifloxacin—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0048	0.00483	CcSEcCtD
Moxifloxacin—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00479	0.00482	CcSEcCtD
Moxifloxacin—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.0047	0.00473	CcSEcCtD
Moxifloxacin—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00469	0.00472	CcSEcCtD
Moxifloxacin—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.00465	CcSEcCtD
Moxifloxacin—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00459	0.00462	CcSEcCtD
Moxifloxacin—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00452	0.00455	CcSEcCtD
Moxifloxacin—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0045	0.00453	CcSEcCtD
Moxifloxacin—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.00443	CcSEcCtD
Moxifloxacin—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.00432	CcSEcCtD
Moxifloxacin—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00424	0.00427	CcSEcCtD
Moxifloxacin—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00418	0.00421	CcSEcCtD
Moxifloxacin—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00414	0.00417	CcSEcCtD
Moxifloxacin—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00412	0.00415	CcSEcCtD
Moxifloxacin—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.00412	CcSEcCtD
Moxifloxacin—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.00412	CcSEcCtD
Moxifloxacin—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00408	0.00411	CcSEcCtD
Moxifloxacin—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00404	0.00406	CcSEcCtD
Moxifloxacin—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00403	0.00405	CcSEcCtD
Moxifloxacin—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.00404	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.00404	CcSEcCtD
Moxifloxacin—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00399	0.00402	CcSEcCtD
Moxifloxacin—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00399	0.00402	CcSEcCtD
Moxifloxacin—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00398	0.00401	CcSEcCtD
Moxifloxacin—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00398	0.00401	CcSEcCtD
Moxifloxacin—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00391	0.00393	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00387	0.0039	CcSEcCtD
Moxifloxacin—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00386	0.00389	CcSEcCtD
Moxifloxacin—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00384	0.00387	CcSEcCtD
Moxifloxacin—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.0037	0.00372	CcSEcCtD
Moxifloxacin—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00369	0.00371	CcSEcCtD
Moxifloxacin—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00368	0.0037	CcSEcCtD
Moxifloxacin—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00368	0.0037	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.00368	CcSEcCtD
Moxifloxacin—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00365	0.00367	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00363	0.00365	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.00364	CcSEcCtD
Moxifloxacin—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.00363	CcSEcCtD
Moxifloxacin—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00354	0.00357	CcSEcCtD
Moxifloxacin—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00343	0.00345	CcSEcCtD
Moxifloxacin—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00334	0.00336	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00331	0.00333	CcSEcCtD
Moxifloxacin—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.00332	CcSEcCtD
Moxifloxacin—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00329	0.00331	CcSEcCtD
Moxifloxacin—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.00324	CcSEcCtD
Moxifloxacin—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.00322	CcSEcCtD
Moxifloxacin—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.00317	CcSEcCtD
Moxifloxacin—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.00316	CcSEcCtD
Moxifloxacin—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.00315	CcSEcCtD
Moxifloxacin—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00311	0.00313	CcSEcCtD
Moxifloxacin—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.0031	CcSEcCtD
Moxifloxacin—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00302	0.00304	CcSEcCtD
Moxifloxacin—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.003	0.00302	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.00299	CcSEcCtD
Moxifloxacin—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.00298	CcSEcCtD
Moxifloxacin—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00294	0.00296	CcSEcCtD
Moxifloxacin—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00293	0.00294	CcSEcCtD
Moxifloxacin—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.0029	CcSEcCtD
Moxifloxacin—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00288	0.00289	CcSEcCtD
Moxifloxacin—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00288	CcSEcCtD
Moxifloxacin—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00279	0.00281	CcSEcCtD
Moxifloxacin—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00277	0.00279	CcSEcCtD
Moxifloxacin—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00278	CcSEcCtD
Moxifloxacin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00273	0.00274	CcSEcCtD
Moxifloxacin—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00273	0.00274	CcSEcCtD
Moxifloxacin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00273	0.00274	CcSEcCtD
Moxifloxacin—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00272	0.00273	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00271	0.00272	CcSEcCtD
Moxifloxacin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00269	0.00271	CcSEcCtD
Moxifloxacin—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00267	0.00268	CcSEcCtD
Moxifloxacin—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.00265	CcSEcCtD
Moxifloxacin—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.00263	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.00263	CcSEcCtD
Moxifloxacin—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.00258	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.00257	CcSEcCtD
Moxifloxacin—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00255	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.00254	CcSEcCtD
Moxifloxacin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00251	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.00239	CcSEcCtD
Moxifloxacin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.00238	CcSEcCtD
Moxifloxacin—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.00236	CcSEcCtD
Moxifloxacin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.00234	CcSEcCtD
Moxifloxacin—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.00234	CcSEcCtD
Moxifloxacin—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.00231	CcSEcCtD
Moxifloxacin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00229	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.00227	CcSEcCtD
Moxifloxacin—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00227	CcSEcCtD
Moxifloxacin—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00225	CcSEcCtD
Moxifloxacin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00225	CcSEcCtD
Moxifloxacin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.00217	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00214	0.00215	CcSEcCtD
Moxifloxacin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.00209	CcSEcCtD
Moxifloxacin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00208	CcSEcCtD
Moxifloxacin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00208	CcSEcCtD
Moxifloxacin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00194	CcSEcCtD
Moxifloxacin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00189	CcSEcCtD
Moxifloxacin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00186	CcSEcCtD
Moxifloxacin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.0018	CcSEcCtD
Moxifloxacin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.00174	CcSEcCtD
Moxifloxacin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00167	CcSEcCtD
Moxifloxacin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00166	CcSEcCtD
Moxifloxacin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00166	CcSEcCtD
Moxifloxacin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00165	CcSEcCtD
Moxifloxacin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00156	CcSEcCtD
